Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bellerophon (BLPH)
OTHER OTC:BLPH
Bellerophon (BLPH) Stock Price & Analysis
500 Followers
BLPH Stock Chart & Stats
Day’s Range$0.05 - $0.06
52-Week Range― - ―
Previous Close$0.05
Volume3.30K
Average Volume (3M)N/A
Market Cap
$649.55K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bellerophon News
PremiumCompany Announcements
Bellerophon Shareholders Vote to Dissolve Amid Board ResignationsPremiumCompany Announcements
Bellerophon Reschedules Special Meeting for Dissolution Vote
PremiumCompany Announcements
Bellerophon Sets Series A Preferred Stock Rights and Privileges
PremiumCompany Announcements
Bellerophon Offers Series A Stock in Private Sale
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BLPH FAQ
What was Bellerophon’s price range in the past 12 months?
Currently, no data Available
What is Bellerophon’s market cap?
Currently, no data Available
When is Bellerophon’s upcoming earnings report date?
Bellerophon’s upcoming earnings report date is May 09, 2024 which is in 23 days.
How were Bellerophon’s earnings last quarter?
Currently, no data Available
Is Bellerophon overvalued?
According to Wall Street analysts Bellerophon’s price is currently Overvalued.
Does Bellerophon pay dividends?
Bellerophon does not currently pay dividends.
What is Bellerophon’s EPS estimate?
Bellerophon’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bellerophon have?
Currently, no data Available
What happened to Bellerophon’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bellerophon?
Among the largest hedge funds holding Bellerophon’s share is Perceptive Advisors LLC. It holds Bellerophon’s shares valued at N/A.
---
Bellerophon Stock Smart Score
Company Description
Bellerophon
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.
---
BLPH Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Benitec Biopharma
―
BioLife Solutions
―
Bioline RX Ltd Sponsored ADR
―
Ovid Therapeutics
―
Best Analysts Covering BLPH
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
+83.46%
reiterated a buy rating 11 months ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of +83.46% per trade.
---